Exodus Point Capital Management, LP Gossamer Bio, Inc. Call Options Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
114Shares Held
190MCall Options Held
405KPut Options Held
490K-
Nea Management Company, LLC Timonium, MD15.8MShares$17.1 Million1.31% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$14.4 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$12.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA9.2MShares$9.93 Million0.31% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$9.92 Million1.7% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $101M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...